ABSTRACT
Transgenic crops, the product of advanced genetic-engineering techniques based on recombinant DNA, started to be commercialized in the mid-1990s. Since well before their commercialization, biotechnology, in general, and transgenic crops, in particular, have been touted as miraculous technologies (Cage, 2008; Lee, 2008; Harvey and Parker, 2008); if only given a chance, they would make deserts bloom and do away with world hunger. The intensity of these assertions has not been tempered by the fact that most transgenic crops are not even geared for direct human consumption. Transgenic crops are sold in volatile global markets as raw materials to produce livestock feed, agro-fuels, cooking oil, and sweeteners, among other products. These are grown in huge industrial monocropping operations (which amount to two-thirds of global food production grown with biotechnology), like soybeans, corn (a fourth of global production), cotton, and canola.
